Rani Therapeutics Holdings Inc. Class A (RANI)
NASDAQ: RANIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
RANI stock chart
Technical analysisKey statistics
All statistics- Market cap
- $114.12M
- EPS (TTM)
- -$0.15
- Dividend yield
- None
- 52-week range
- 0.445 – 3.87
- Day range
- 0.79 – 0.8369
- Volume / Avg
- 232.17K / 754.21K
- Beta
- —
- Shares outstanding
- 115.42M
- Next earnings
- Nov 5, 2026
52-week range
RANI stock today
On Oct 7, RANI ended the session at $0.8121, shedding $0.0167 (2.01%), versus the S&P 500's 0.22% decline. Trading was light, with 232.17K shares changing hands, about 31% of the average daily volume. At this level, RANI sits near the bottom of its 52-week range of $0.445 to $3.87: 79.0% below the high, set on Oct 22, 2025 and 82.5% above the low.
RANI is down 39.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 62.4%. Rani Therapeutics has posted a net loss over the last twelve months (EPS of -$0.15), so its P/E ratio is not meaningful. Rani Therapeutics's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Rani Therapeutics
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.05
Rani Therapeutics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| COYACoya Therapeutics Inc. | 4.91 | +1.24% | $115.18M | vs RANI |
| UNCYUnicycive Therapeutics Inc. | 4.18 | -1.18% | $114.50M | vs RANI |
| GNLXGenelux Corporation | 2.52 | -0.79% | $114.02M | vs RANI |
| PMVPPMV Pharmaceuticals Inc. | 1.50 | -6.83% | $113.27M | vs RANI |
| INOInovio Pharmaceuticals Inc. | 1.16 | +2.21% | $119.42M | vs RANI |
| QUCYQuantum Cyber N.V. | 1.43 | +10.85% | $120.22M | vs RANI |
| AARDAardvark Therapeutics Inc. | 4.96 | -1.59% | $108.55M | vs RANI |
| VTVTvTv Therapeutics Inc. Class A | 31.01 | +3.26% | $122.61M | vs RANI |
Indexes, lists and sector
Rani Therapeutics stock FAQ
What is Rani Therapeutics's stock price today?
RANI last traded at $0.8121 as of Oct 7, 4:00 PM EDT, down 2.01% on the day. Prices are delayed at least 15 minutes.
When is Rani Therapeutics's next earnings date?
Rani Therapeutics is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.05.
What is the RANI 52-week high?
The 52-week high for RANI is $3.87 and the 52-week low is $0.445. The stock is currently 79.0% below its high.